{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-276065","form_type":"8-K","ticker":"MPLT","cik":"0001770069","company_name":"MapLight Therapeutics, Inc.","filed_at":"2026-06-18T21:00:35+00:00","discovered_at":"2026-06-18T21:02:00.312010+00:00","generated_at":"2026-06-18T21:03:46.569264+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"MapLight Therapeutics fires CFO Vishwas Setia for HR violation; interim CFO named","bullets":["Vishwas Setia separated as CFO effective June 18, 2026, due to human resources violation; no severance paid.","Separation is unrelated to financial/operational results, internal controls, or clinical programs.","Jonathan Gillis, Chief Administrative and Accounting Officer, appointed interim CFO and principal financial officer.","Gillis continues as principal accounting officer; background in April 2026 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-276065","json":"https://secwatch.observer/filing/0001193125-26-276065.json","markdown":"https://secwatch.observer/filing/0001193125-26-276065.md","text":"https://secwatch.observer/filing/0001193125-26-276065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526276065/0001193125-26-276065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526276065/d227825d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T21:03:46.569264+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e27f733d7","claim":"Vishwas Setia departed as Chief Financial Officer at MapLight Therapeutics, Inc..","evidence_excerpt":"Vishwas Setia was separated as the Chief Financial Officer of MapLight Therapeutics, Inc. (the “Company”), effective immediately, following a review of a human resources violation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526276065/0001193125-26-276065-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"6a175300c0","claim":"Jonathan Gillis was appointed as interim Chief Financial Officer at MapLight Therapeutics, Inc..","evidence_excerpt":"the board of directors of the Company appointed Jonathan Gillis, the Company’s Chief Administrative and Accounting Officer, as the Company’s interim Chief Financial Officer and interim principal financial officer, effective June 18, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526276065/0001193125-26-276065-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}